Sclerosis: all 3,103 studies
Page 28 of 32. Open to participants first (314), then studies with results posted, then the rest; newest registration first within each.
- Pharmacogenetic Trial and Long-term Follow-up of the PRISMS Trial (PRISMS-15)CompletedNCT01034644
- Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)CompletedNCT01031901Phase 1
- Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.CompletedNCT01031459
- Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy VolunteersCompletedNCT01031199Phase 1
- Novel Immune Markers in Patients With Multiple SclerosisStatus unknownNCT01026272
- Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple SclerosisCompletedNCT01024777Phase 1
- Memantine Therapy in Amyotrophic Lateral SclerosisCompletedNCT01020331Phase 2
- The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) TremorCompletedNCT01018485Phase 3
- Safety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT01016522Phase 3
- Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety StudyCompletedNCT01006941Phase 2
- The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis PatientsTerminatedNCT01005095Phase 4
- Doxycycline In Lymphangioleiomyomatosis (LAM)CompletedNCT00989742Phase 4
- The Effects of Ethyl-Alpha-Guanido-Methyl Ethanoate on Skin Reactions From Glatiramer Acetate InjectionsWithdrawnNCT00988988Phase 4
- Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)WithdrawnNCT00986960Phase 2
- Efficacy and Safety of Methylprednisolone Per os Versus IV for the Treatment of Multiple Sclerosis (MS) RelapsesStatus unknownNCT00984984Phase 3
- Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary HypertensionCompletedNCT00984932Phase 3
- Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT00982150Phase 2
- Effects of Meditation on Multiple Sclerosis and Peripheral NeuropathyCompletedNCT00981643Not applicable
- A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).TerminatedNCT00978536Not applicable
- Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple SclerosisCompletedNCT00972062Not applicable
- Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological ConditionsCompletedNCT00970333Phase 1
- Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)Status unknownNCT00962923Phase 1/2
- Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple SclerosisCompletedNCT00959218Phase 3
- Small Intestinal Mucosal Abnormalities in Systemic Sclerosis Using Capsule EndoscopyCompletedNCT00958672
- Effects of Nocturnal Non-invasive Ventilation in Patients With Amyotrophic Lateral SclerosisCompletedNCT00958048Not applicable
- Assessment of Postural Orientation and Equilibrium In Early Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00956501
- Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral AclerosisCompletedNCT00956488Phase 1/2
- Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) MethylprednisoloneTerminatedNCT00947895Phase 2/3
- Motivational Interviewing to Increase Physical Activity to Treat Depression in People Aging With MS or SCICompletedNCT00947232Not applicable
- The Effect of Physical Therapy on Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT00946738Not applicable
- TakeCharge: Telephone Delivered Self-management Intervention for People With Multiple Sclerosis (MS)CompletedNCT00944190Not applicable
- Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1bCompletedNCT00942591Phase 2
- Biomarkers and Response to Natalizumab for Multiple Sclerosis TreatmentCompletedNCT00942214Phase 4
- Vitamin D3 Supplementation and the T Cell Compartment in Multiple Sclerosis (MS)CompletedNCT00940719Not applicable
- Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) StudyCompletedNCT00937677
- Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis PatientsCompletedNCT00928967
- Rajavtihi Neuronal Adult Stem Cells ProjectWithdrawnNCT00927108Phase 2
- Effect of Lithium Carbonate in Patients With Amyotrophic Lateral SclerosisCompletedNCT00925847Phase 2
- Progression of Cognitive and Physical Symptoms in Multiple SclerosisWithdrawnNCT00922831
- Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00919555Phase 1/2
- The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple SclerosisStatus unknownNCT00917839Phase 2
- Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex SyringeCompletedNCT00915577Phase 3
- Open-Label Safety Extension Study of AvonexCompletedNCT00915460Phase 4
- Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)Status unknownNCT00914758
- A Study With IPX056 in Subjects With Spasticity Associated With Multiple SclerosisCompletedNCT00914290Phase 2
- Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy VolunteersCompletedNCT00913666Phase 4
- A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy VolunteersCompletedNCT00913250Phase 1
- Immunogenicity and Safety Study of Serum-Free AvonexCompletedNCT00912860Phase 2
- Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS)Status unknownNCT00910598Phase 4
- Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait AbnormalitiesCompletedNCT00906737Not applicable
- Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH)CompletedNCT00902135
- Efficacy and Safety of YAM80 in Amyotrophic Lateral Sclerosis (ALS)Status unknownNCT00886977Phase 2
- Effects of Tysabri (BG00002) Over 12 Months on MS Related Fatigue in Participants With RRMSCompletedNCT00884481
- Physical Activity and Fatigue in Early Multiple Sclerosis (MS)CompletedNCT00882453
- Nocturnal PtcCO2 Monitoring in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00879593Not applicable
- Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00876772Phase 2/3
- First Time in Human Study of GSK1223249 in Amyotrophic Lateral SclerosisCompletedNCT00875446Phase 1
- Physical Disability in Patients Treated With BetaferonCompletedNCT00873340
- Effect of Robot-assisted Training on Foot Drop in Multiple SclerosisCompletedNCT00872053Phase 1/2
- A Study for Patients With Multiple SclerosisTerminatedNCT00870155Phase 2/3
- A Study for Patients With Relapsing Remitting Multiple SclerosisCompletedNCT00869986Phase 2/3
- A Study for Patients With Secondary Progressive Multiple SclerosisCompletedNCT00869726Phase 2/3
- A Randomized Exercise Trial for Wheelchair UsersCompletedNCT00866112Not applicable
- Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton SpectroscopyCompletedNCT00861172Not applicable
- Differential Immune Effects of NatalizumabCompletedNCT00859482
- Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral SclerosisCompletedNCT00855400Phase 1/2
- Modeling and Treating the Pathophysiology of Demyelination in Multiple SclerosisTerminatedNCT00854750Phase 4
- Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate MofetilCompletedNCT00853788
- Low Fat Diet and Multiple SclerosisCompletedNCT00852722Phase 1
- Pharmacokinetics of Oral Treprostinil in Patients With Systemic SclerosisCompletedNCT00848939Phase 1
- Neuromuscular Transmission in Amyotrophic Lateral SclerosisCompletedNCT00847847Not applicable
- Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)WithdrawnNCT00846560
- Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor OveractivityTerminatedNCT00845338Phase 2
- The Effectiveness of Locomotor Therapy Using Robot-Driven Gait Orthosis System in Multiple Sclerosis PatientsCompletedNCT00843128Phase 2
- Investigation of Coronary and Pulmonary Circulatory Parameters in Systemic SclerosisCompletedNCT00843102
- Muscle Ultrasound: A New Tool for Measuring Progression in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00838617
- A 24-Hour Pharmacokinetic Determination of BG00012 After Single-Day Oral Administration in Subjects With MSCompletedNCT00837785Phase 1
- Lokomat Treadmill Training Effects on MS GaitCompletedNCT00835835Not applicable
- Repetitive Transcranial Magnetic Stimulation (rTMS) in Amyotrophic Lateral SclerosisCompletedNCT00833820Phase 2/3
- Genetics of Familial and Sporadic ALSCompletedNCT00821132
- Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple SclerosisCompletedNCT00819195
- Therapy Optimization in Multiple Sclerosis (MS)CompletedNCT00819000
- Characteristic Study on Chinese Patients With Multiple SclerosisStatus unknownNCT00818103Not applicable
- A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder FunctionCompletedNCT00818038
- Autologous Mesenchymal Stem Cell (MSC) Transplantation in MSCompletedNCT00813969Phase 1
- Randomized Placebo-Controlled Crossover Trial With THC (Delta 9-Tetrahydrocannabinol) for the Treatment of Cramps in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00812851Not applicable
- Regional Cortical Cerebral Quantitative MRI Perfusion Correlation Neurocognition in Multiple SclerosisCompletedNCT00812474
- Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple SclerosisCompletedNCT00811902Phase 2
- Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00809224
- A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral SclerosisCompletedNCT00800501Phase 1/2
- Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)CompletedNCT00792766Phase 1/2
- Can Vitamin D Supplementation Prevent Bone Loss in Persons With Multiple SclerosisCompletedNCT00785473Phase 4
- Mesenchymal Stem Cells for the Treatment of MSCompletedNCT00781872Phase 1/2
- Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple SclerosisCompletedNCT00772525Phase 2
- A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-aWithdrawnNCT00771043Phase 4
- Lokomat Training Effects on MS Gait AbnormalitiesTerminatedNCT00766272Phase 1/2
- Targeted Lower Extremity Joint TrainingTerminatedNCT00765544Phase 1/2
- Chronotherapy in Acute Multiple Sclerosis (MS) AttackTerminatedNCT00764413Not applicable
- Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During RelapseCompletedNCT00753792Phase 4
- Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical ResponseStatus unknownNCT00753571Phase 2